Incyte Corporation is a global biopharmaceutical company headquartered in Wilmington, Delaware, USA. Founded in 1991, Incyte focuses on the discovery, development, and commercialization of innovative medicines to address serious unmet medical needs. The company's mission is to improve the lives of patients through scientific innovation, with a strong emphasis on oncology, inflammation, and autoimmunity. Incyte has established itself as a leader in targeted therapies, particularly with its flagship product Jakafi® (ruxolitinib), which is widely used in the treatment of myelofibrosis and polycythemia vera.
With over 2,000 employees worldwide, Incyte operates a robust research pipeline and collaborates with other pharmaceutical and biotech companies to advance novel treatments. The company has received recognition for its strong R&D capabilities and has expanded its portfolio to include dermatology and hematology-oncology products. Recent developments include regulatory approvals for new indications of existing drugs and promising results from late-stage clinical trials. Incyte's reputation in the biopharma industry is marked by its commitment to scientific excellence and patient-centric innovation.
No open positions at Incyte right now. Check back later!
Browse All Jobs →